WhatFinger

100 reports of Guillain-Barré syndrome have been confirmed so far

FDA to Add Warning About Neurological Disorder Linked to Johnson & Johnson COVID-19 Vaccine

By Epoch Times ——--July 13, 2021

News Headlines | CFP Comments | Reader Friendly | Subscribe | Email Us

The U.S. Food and Drug Administration (FDA) on July 12 said it will add a warning label to Johnson & Johnson’s COVID-19 vaccine that it is linked to a rare neurological disorder known as Guillain-Barré syndrome (GBS), while J&J confirmed it is “in discussions” with federal agencies. “The FDA is announcing revisions to the vaccine recipient and vaccination provider fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination,” an FDA spokesperson told The Epoch Times on July 12.-- More...

Support Canada Free Press

Donate
Subscribe

View Comments
Epoch Times——

The Epoch Times: “A Fresh Look at Our Changing World”

The Epoch Times is a privately held news media company. The center is in New York, but our network of local reporters throughout the world uncovers stories that are authentically local, yet also globally relevant. Our independence enables us to report widely and present a diversity of opinions.

 

We have offices in 30 countries across five continents, and our content is published in 17 languages. We are proud to offer print and web editions in Chinese, English, German, French, Spanish, Hebrew, Russian, Japanese, Korean and Indonesian, as well as web versions in Ukrainian, Bulgarian, Romanian, Czech, Slovak, Vietnamese and Swedish.

VIEW Comments

Sponsored